Latest Videos |view all videos
Diagnosis and treatment of adult congenital heart disease
Mayo Clinic heart specialists discuss optimal management of congenital heart disease in adult patients.
Congenital heart disease arrhythmias march to their own beat
Bryan C. Cannon, M.D., and Christopher J. McLeod, M.B., Ch.B., Ph.D., discuss atrial and ventricular arrhythmia in complex congenital heart disease with Alexander C. Egbe, M.B.B.S.
Updates in ventricular assist device (VAD) technology (Part 3 of 3-part video series)
VAD experts John M. Stulak, M.D., Sudhir Kushwaha, M.D., Sarah D. Schettle, P.A.-C., M.S., and Gayatri A. Acharya, M.D., discuss current updates in ventricular assist device technology and the benefits to patients living with advanced heart failure.
Ventricular assist device surgical procedures and postoperative care (Part 2 of 3-part video series)
Mayo Heart Failure experts John M. Stulak, M.D., Sudhir Kushwaha, M.D., Sarah D. Schettle, P.A.-C., M.S., and Gayatri A. Acharya, M.D., review ventricular assist device surgical procedures and post-care for advanced heart failure patients.
The value of social media in academic medicine: What are the data?
In this video, Robert (R Jay) J. Widmer, M.D., Ph.D., Interventional Cardiology fellow at Mayo Clinic, discusses the value of social media in academic medicine.
Strengthening the HLHS heart with regenerative medicine
Regenerative medicine — the ability to bioengineer and make new heart muscle and apply it to patients with weak hearts — is changing the future for children with hypoplastic left heart syndrome.
Grand Rounds: What Is 'Heart-Healthy Nutrition,' and why Is it so Hard to Define?
In this Grand Rounds presentation, Stephen L. Kopecky, M.D., Cardiovascular Diseases specialist at Mayo Clinic's campus in Rochester, Minnesota, discusses heart-healthy nutrition.
Plasma ceramides — A novel biomarker of unstable atherosclerotic cardiovascular disease
Jeffrey W. (Jeff) Meeusen, Ph.D., discusses studies of plasma ceramides in three different patient populations.